<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Startup on женатик</title>
    <link>http://genat.uk/tags/startup/</link>
    <description>Recent content in Startup on женатик</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 2017 Vladimir Kiselev</copyright>
    <lastBuildDate>Tue, 20 Oct 2015 20:23:30 +0000</lastBuildDate>
    
	<atom:link href="http://genat.uk/tags/startup/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>How medicine turns into advertising</title>
      <link>http://genat.uk/post/2015-10-20-how-medicine-turns-into-advertising/</link>
      <pubDate>Tue, 20 Oct 2015 20:23:30 +0000</pubDate>
      
      <guid>http://genat.uk/post/2015-10-20-how-medicine-turns-into-advertising/</guid>
      <description>I have just learnt about some tension growing around Theranos biotech startup. Looks like their advertisement strategy worked very well, giving them more than 400 million dollars of investments. However, now the whole technology is under a big question. The topic is familiar to me because last year I took part in the Biotechnology YES competition and my team presented a similar idea of diagnosing cancer relapse from a blood test.</description>
    </item>
    
  </channel>
</rss>